| Suspended | Study to Assess Epidural Resiniferatoxin for the Treatment of Intractable Pain Associated With Advanced Cancer Pain, Intractable, Pain Cancer, Pain | Phase 2 | 2025-09-01 |
| Suspended | Study to Assess Abivertinib in Combination With Abiraterone in Metastatic Castration Resistant Prostate Cancer Prostate Cancer, Prostate Cancer Metastatic | Phase 2 | 2025-09-01 |
| Withdrawn | Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells to Treat Post COVID-19 "Long Haul" Pulmonary Compro Covid19 | Phase 2 | 2024-02-01 |
| Withdrawn | An Open-Label Study of the Safety of an Anti-CD38 Antibody Drug Conjugate (STI-6129) in Patients With AL Amylo Light Chain (AL) Amyloidosis | Phase 1 | 2023-09-01 |
| Not Yet Recruiting | Study to Assess the Safety and Preliminary Efficacy of STI-1386 Oncolytic Virus in Relapsed or Refractory Soli Cancer, Cancer of Pancreas, Sarcoma | Phase 1 | 2023-08-01 |
| Withdrawn | Study to Evaluate the Efficacy of IN STI-9199 in Treating Symptomatic COVID-19 in Outpatient Adults and Adoles COVID-19 | Phase 2 | 2023-04-01 |
| Withdrawn | A Study of STI-3031 (an Anti-PD-L1 Antibody) in Patients With Selected Relapsed/Refractory Malignancies Peripheral T Cell Lymphoma, Diffuse Large B Cell Lymphoma, Biliary Tract Cancer | Phase 2 | 2023-03-01 |
| Unknown | Study to Access Anti-CD38 Anibody Drug in Patients With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 | 2023-03-01 |
| Active Not Recruiting | Study to Assess Anti-CD38 Antibody Drug Conjugate in Relapsed or Refractory Multiple Myeloma Multiple Myeloma | Phase 1 / Phase 2 | 2023-02-01 |
| Withdrawn | Study to Assess an Anti-Trop2 Antibody Drug Conjugate in Relapsed or Refractory Solid Tumors Relapsed Solid Neoplasm, Refractory Cancer, Solid Tumor, Adult | Phase 1 | 2022-12-01 |
| Unknown | Study to Assess Allogeneic Anti-CD38 A2 Dimeric Antigen Receptor T Cells in Relapsed or Refractory Multiple My Multiple Myeloma | Phase 1 | 2022-10-01 |
| Unknown | Pembrolizumab Administered Via the Sofusa® DoseConnect™ in Patients With Relapsed/Refractory Cutaneous T-cell Mycosis Fungoides | Phase 1 | 2022-08-31 |
| Completed | Study to Assess the Safety, Tolerability and Pharmacokinetics of STI-1558 in Healthy Volunteers COVID-19 | Phase 1 | 2022-06-07 |
| Unknown | Study of the Safety and Efficacy of STI-6643 in Subjects With Advanced Solid Tumors Solid Tumor, Relapsed Solid Neoplasm, Refractory Tumor | Phase 1 | 2021-11-24 |
| Terminated | Study of Intravenous COVI-MSC for Treatment of COVID-19-Induced Acute Respiratory Distress Covid19 | Phase 2 | 2021-11-16 |
| Completed | Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With COVID-19 (US) Covid19 | Phase 2 | 2021-11-16 |
| Unknown | Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distres Covid19 | Phase 2 | 2021-11-16 |
| Unknown | Study to Evaluate Intra-articular Resiniferatoxin to Treat Moderate to Severe Pain From Knee Osteoarthritis Osteoarthritis, Knee, Knee Osteoarthritis, Knee Pain Chronic | Phase 2 | 2021-11-15 |
| Withdrawn | Randomized Study to Evaluate Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With Mild COVID-19 COVID-19 | Phase 2 | 2021-11-01 |
| Withdrawn | Study of Anti-CEA CAR-T + Chemotherapy VS Chemotherapy Alone in Patients With CEA+Pancreatic Cancer & Liver Me Malignant Tumor of Pancreas Metastatic to Liver | Phase 2 / Phase 3 | 2021-11-01 |
| Withdrawn | Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrom Acute Respiratory Distress Syndrome, Ards | Phase 2 | 2021-09-01 |
| Withdrawn | Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells to Treat Post COVID-19 "Long Haul" Pulmonary Compro Covid19 | Phase 2 | 2021-08-01 |
| Terminated | Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With COVID-19 (UK) Covid19 | Phase 2 | 2021-07-16 |
| Enrolling By Invitation | Long-Term Follow-Up of Patients Who Received Gene-Modified Cell Therapy Long-term Follow-up | — | 2021-06-16 |
| Withdrawn | Study of STI-3031 in Patients With Selected Relapsed or Refractory Solid Tumors Solid Tumor, Refractory Tumor, Relapsed Solid Tumor | Phase 2 | 2021-06-01 |
| Withdrawn | Study to Evaluate the Safety and Efficacy of a Single Dose of STI-2020 (COVI-AMG™) to Treat COVID-19 Covid19 | Phase 1 / Phase 2 | 2021-04-01 |
| Withdrawn | Study to Evaluate a Single Dose of STI-2020 (COVI-AMG™) in Adults With Mild COVID-19 Symptoms Covid19 | Phase 2 | 2021-04-01 |
| Unknown | Study of the Safety and Efficacy of STI-6129 in Patients With Relapsed or Refractory Systemic AL Amyloidosis Light Chain (AL) Amyloidosis | Phase 1 / Phase 2 | 2021-04-01 |
| Withdrawn | Study to Evaluate a Single Dose of STI-2020 (COVI-AMG™) in Hospitalized Adults With COVID-19 Covid19 | Phase 2 | 2021-04-01 |
| Withdrawn | Study to Evaluate Resiniferatoxin in Patients With Knee Osteoarthritis Whose Total Knee Replacement Surgery is Osteoarthritis, Knee, Osteo Arthritis Knee, Knee Pain Chronic | Phase 3 | 2021-04-01 |
| Unknown | Study to Assess the Safety and Efficacy of Enbrel Administered by Sofusa DoseConnect for Rheumatoid Arthritis Rheumatoid Arthritis | Phase 1 | 2021-03-15 |
| Withdrawn | Study of Intravenous Administration of Allogeneic Adipose-Derived Mesenchymal Stem Cells for COVID-19-Induced Covid19, ARDS | Phase 2 | 2021-03-01 |
| Completed | Study of the Safety and Efficacy of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized Due to COVID-19 Covid19 | Phase 2 | 2021-01-06 |
| Completed | Study of Intravenous Administration of Allogeneic Adipose Stem Cells for COVID-19 Covid19 | Phase 1 | 2020-12-15 |
| Withdrawn | Study to Evaluate the Safety, Pharmacokinetics and Efficacy of STI-2020 (COVI-AMG™) in Outpatients With COVID- Covid19 | Phase 1 / Phase 2 | 2020-12-01 |
| Withdrawn | Phase 3 Study to Assess Resiniferatoxin vs Standard of Care for the Treatment of Intractable Cancer Pain Pain, Intractable, Pain Cancer | Phase 3 | 2020-12-01 |
| Withdrawn | A Phase 3 Study to Evaluate the Efficacy and Safety of Resiniferatoxin for Pain Due to Osteoarthritis of the K Osteoarthritis, Knee, Knee Pain Chronic | Phase 3 | 2020-12-01 |
| Completed | Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized With COVID-19 Covid-19 | Phase 2 | 2020-10-09 |
| Withdrawn | Study to Evaluate STI-1499 (COVI-GUARD) in Patients With Moderate COVID-19 Covid-19 | Phase 1 | 2020-09-01 |
| Terminated | Phase 1b Study of CAR2Anti-CEA CAR-T Cell Hepatic Infusions for Pancreatic Carcinoma Patients With CEA+ Liver Metastatic Pancreatic Carcinoma | Phase 1 | 2019-07-29 |
| Completed | Study to Evaluate the Safety and Efficacy of Anti-CD38 CAR-T in Relapsed or Refractory Multiple Myeloma Patien Relapsed or Refractory Multiple Myeloma | Phase 1 | 2018-10-15 |
| Withdrawn | CAR-T Intraperitoneal Infusions for CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites ( Peritoneal Carcinomatosis, Peritoneal Metastases, Colorectal Cancer | Phase 1 | 2018-09-13 |
| Completed | Study of Resiniferatoxin for Knee Pain in Moderate to Severe Osteoarthritis Osteoarthritis, Knee, Pain, Knee | Phase 1 | 2018-07-12 |
| Completed | Sofusa System With Sumatriptan (KC5010) Phase 1 Dose Escalation Safety and PK Study (KCC-SMT-002) Migraine Disorders | Phase 1 | 2018-01-17 |
| Completed | Study to Evaluate Safety and MTD of Epidural Resiniferatoxin Injection for Treatment of Intractable Cancer Pai Intractable Cancer Pain | Phase 1 | 2017-09-01 |
| Completed | Bioequivalence Study of IG-001 Versus Nab-paclitaxel in Metastatic or Locally Recurrent Breast Cancer Metastatic Breast Cancer, Locally Recurrent Breast Cancer | N/A | 2014-03-01 |